The reduction in CSF NPTX2 compared to non-trisomic cognitively normal controls was observed in DS across all AD stages and was similar to the reduction observed in sporadic AD patientsboth here and in previous studies [12, 15]. The gene discussed is NPTX2; the disease is Alzheimer disease.